Cargando…
Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure
Activation, infection, and eventual depletion of human immunodeficiency virus (HIV)-specific cluster of differentiation 4 (CD4) T cells are the crucial pathogenetic events in acquired immunodeficiency syndrome (AIDS). We developed a cell and gene therapy to reconstitute HIV-specific CD4 T cells and...
Autores principales: | Li, Haishan, Lahusen, Tyler, Xiao, Lingzhi, Muvarak, Nidal, Blazkova, Jana, Chun, Tae-Wook, Pauza, C. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240062/ https://www.ncbi.nlm.nih.gov/pubmed/32462053 http://dx.doi.org/10.1016/j.omtm.2020.04.024 |
Ejemplares similares
-
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
por: Muvarak, Nidal, et al.
Publicado: (2022) -
Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models
por: Liou, Mei-Ling, et al.
Publicado: (2022) -
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
por: Pauza, C. David, et al.
Publicado: (2018) -
Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice
por: Gándara, Carolina, et al.
Publicado: (2018) -
Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells
por: Li, Haishan, et al.
Publicado: (2013)